Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo

Nature Medicine

Volumn 1, Issue 6, 1995, Pages 541-545

  Indolfi, Ciro ^a   Awedimento, Enrico V ^b   Rapacciuolo, Antonio ^a   Di Lorenzo, Emilio ^a   Esposito, Giovanni ^a   Stabile, Eugenio ^a   Feliciello, Antonio ^c   Mele, Evelina ^b   Giuliano, Paola ^c   Condorelli, Gianluigi ^d   Chiariello, Massimo ^a  

^a Seconda Universita'di Napoli   (Italy)

^b Dipartimento di Medicina Sperimentale e Clinica   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BLOOD VESSEL INJURY; CELL PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

ANIMAL; BALLOON DILATATION; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CELL DIVISION; DNA, RECOMBINANT; GENE THERAPY; GENES, RAS; MUSCLE, SMOOTH, VASCULAR; POINT MUTATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEIN P21(RAS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RAF; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; SUPPORT, NON-U.S. GOV'T; TRANSFECTION;

EID: 0029073183     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0695-541     Document Type: Article

References (40)

1. Virmanl, R., Farb, A. and Burke, A.P. Coronary angioplasty from the perspective of atherosclerotic plaque: Morphologic predictors of immediate success and restenosis. Am. Heart J. 127, 163-179 (1994).
2. McBride, W. et al. Restenosis after successful coronary angioplasty. New Engl. J. Med. 318, 1734-1737 (1988).
3. Bourassa, M. Silent myocardial ischemia after coronary angioplasty: Distinguishing the shadow from the substances. J.A.C.C. 19, 1410-1411 (1992).
4. Holmes, D.R. Jr. et al. Restenosis after percutaneous transluminal coronary angioplasty (coronary angioplasty): A report from the PTC A registry of the National Heart, Lung and Blood Institute. Am. J. Cardiol. S3, 77C-81C (1984).
5. Ross R. The pathogenesis of atherosclerosis, a perspective for the 1990's. Nature 362, 801-809 (1993).
6. Benditt, E.P. and Bendltt, J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. natn. Acad. Sci. U.S.A. 70, 1753-1756 (1973).
7. Speir, E. et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391-394 (1994).
8. Madrl, J.A., Reidy, M.A., Kocher, O. and Bell, L. Endothelial cell behaviour after denudation injury is modulated by transforming growth factor-fi, - and fibronectin. Lab. Invest. 60, 755-765 (1989).
9. Edelman, E.R., Nugent, M.A., Smith, L.T, and Karnovsky, M.J. Basic fibroblast growth factor enhances the coupling of Intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J. din. Invest. 89, 465-473 (1992).
10. Jawien, A., Bowen-Pope, D.F., Lindner, V., Schwartz, S.M., St Clowes, A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. din. Invest. 89, 507-511 (1992).
11. Bourne H.R., Sanders, D A., St McCormick, F. The GTPase superfamily: Conserved structure and molecular mechanism. Nature 349, 117-127 (1991).
12. Boguski, M.S, St McCormick, F. Proteins regulating ras and its relatives. Nature 366, 643-654 (1993).
13. Feramisco, J.R., Gross, M., Kamata, T., Rosenberg, M. St Sweet, R.W. Microinjection of the oncogene form of human H-rds (T-24) protein results in rapid proliferation of quiescent cells, Cell 38, 109-117 (1984).
14. Stacey, D.W. St Rung, H.F. Transformation of NIH3T3 cells by microinjection of Ha-raj p21 protein. Nature 310, 508-511 (1984).
15. Thomas, S.M., De Marco, M., D' Arcangelo, G., Halegoua, S. St Brugge, J.S. Ras is essential for nerve growth factor and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 68, 1031-1040 (1992).
16. Hallberg, B., Rayter, S.I., St Downward, J. Interaction of ras and raf in intact mammalian cells upon extracellular stimulation. J. biol. Chem. 269, 3913-3916 (1994).
17. Kolch, W. et al. Protein kinase Ca activates Raf-1 by direct phosphorylation Nature 364, 249-252 (1993).
18. Marhall, C.J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185 (1995).
19. Cai, H., Szeberenyi, J. St Cooper, G.M. Effect of a dominant inhibitory Haras mutation on mitogenic signal transduction on N1H 3T3 cells. Molec. cell. Biol. 10, 5314-5323 (1990).
20. Felg, L.A. St Cooper, G.M. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Molec. cell. Biol. 8, 3235-3243 (1988).
21. Bollag, G. Sr., McCormick, F.A. Regulators and effectors of ras proteins. Rev. Cell Biol. 7, 601-632 (1991).
22. Lai, C.C., Boguski, M., Brqek, D. Sr., Powers, S. Influence of guanine nucleotides on complex formation between ras and CDC25 proteihs. Molec. cell. Biol. 13, 1345-1352 (1993).
23. Medema, R.H., Wubbolts, R. St Bos, J.L. Two dominant inhibitory mutants of p2T“interfere with insulin-induced gene expression. Molec. cell. Biol. 11, 5963-5967 (1991).
24. Gibbs, J.B., Schaber, M.D., Schofield, T.L. Sr Scolnick E.M. Xenopus oocyte germinal-vesicle breakdown induced by [Val12] ras is inhibited by a cytosol- localized ras mutant. Proc. natn. Acad. Sci. lJ.S-A. 86, 6630-6634 (1989).
25. Michaeli, T., Field, J., Ballester, R., O’Niel, K.O. St Wigler, M. Mutants of H-ras that interfere with ras effector function in Saccharomyces cerevisiae. EMBO J. 8, 3039-3044 (1989).
26. Willumsen, B.M., Morris, K., Papageorge, A.G., Hubbert, N.L. St Lowy, D.R. Harvey murine sarcoma virus p21 ras protein: Biological and biochemical significance of the cysteine nearest the carboxy terminus. EMBO J. 3, 2581-2585 (1984).
27. Vogel, U.S. et al. Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 335, 90-93 (1988).
28. Serruys, P.W. et al. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon: A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 77, 361-371 (1989)
29. Powell, J.S. et al. Inhibitors of angiotensin-converting enzyme prevent neointimal proliferation after vascular injury. Science 245, 186-188 (1990).
30. The Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) study group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 86, 100-110(1991).
31. Herrmann, J.P., Hermaps, W.R., Vos, J. and Serruys, P.W. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II). Drugs 46, 249-262 (1993).
32. Mulchay, L.S., Smith, M.R. and Stacey, D.W. Requirement for ras protooncogene function during serum-stimulated growth of NIH3T3 cells. Nature 313, 241-243 (1985).
33. Carney, W.P. et al. Monoclonal antibodies for detection of normal and oncogenic ras p21. in Human Tumor Antigens and Specific Tumor Therapy (eds Metzagar, R.S., £ Mitchell, M.S.) 53-62 (Liss, New York, 1989).
34. Simons, M., Edelman, E.R., DeKeyser, J.L., Langer and Rosenberg, R.D. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359, 67-70 (1992).
35. Epstein, S.E., Speir, E. and Finkel, T. Do antisense approaches to the problem of restenosis make sense? Circulation 88, 1351-1353 (1993).
36. Clowes, A.W., Reidy, M.A. and Clowes, N.M. Kinetics of cellular proliferation after arterial injury: I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49, 327-337 (1983).
37. Indolfi, C. et al. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation (in the press) (1995).
38. Blumer, K.J. and Johnson, G.L. Diversity in function and regulation of MAP Kinase pathways. Trends Biol. Sci. 19, 236-240 (1994).
39. Porras, A., Muszynski, K., Rapp, U.R. and Santos, E. Dissociation between activation of Raf-1 kinase and the 42-kDa mitogen-activated protein ki- naseJ90-kDa S6 kinase (MAPKJRSK) cascade in the insulinJras pathway of adipocytic differentiation of 3T3 LI cells. J. biol. Chem. 269, 12741-12748 (1994).
40. Dixon, W.J. and Massey, J. Jr Introduction to Statistical Analysis (New York, McGraw-Hill, 1969).